September 22, 2024 In Memoriam: Christopher David Marsden Fletcher, MD, FRCPath, Department of Pathology Read the story Read more In Memoriam: Christopher David Marsden Fletcher, MD, FRCPath, Department of Pathology Read the story
September 11, 2024 FDA Grants Orphan Drug Designation to Elraglusib for Soft Tissue Sarcomas Read the story Read more FDA Grants Orphan Drug Designation to Elraglusib for Soft Tissue Sarcomas Read the story
August 27, 2024 FDA Approves Engineered Cell Therapy for Advanced Synovial Sarcoma Read the story Read more FDA Approves Engineered Cell Therapy for Advanced Synovial Sarcoma Read the story
